Alcon annual shareholders’ equity
2007
2008
2009
2010
2017
2018
2019
2020
2021
2022
2023
2024
2025
Alcon Shareholders’ Equity Growth & History (ALC)
Alcon's shareholders’ equity was $22.03B for fiscal 2025.
View full Alcon company overviewAlcon annual shareholders’ equity history
| Fiscal year | Period ended | Shareholders’ equity | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $22.03B | $481.0M | +2.23% |
| 2024 | 2024-12-31 | $21.55B | $929.0M | +4.50% |
| 2023 | 2023-12-31 | $20.62B | $947.0M | +4.81% |
| 2022 | 2022-12-31 | $19.68B | $421.0M | +2.19% |
| 2021 | 2021-12-31 | $19.26B | $434.0M | +2.31% |
| 2020 | 2020-12-31 | $18.82B | −$481.0M | −2.49% |
| 2019 | 2019-12-31 | $19.30B | −$3.34B | −14.74% |
| 2018 | 2018-12-31 | $22.64B | −$390.0M | −1.69% |
| 2017 | 2017-12-31 | $23.03B | — | — |
| 2010 | 2010-12-31 | $7.25B | $1.35B | +22.81% |
| 2009 | 2009-12-31 | $5.91B | $1.21B | +25.88% |
| 2008 | 2008-12-31 | $4.69B | $1.32B | +38.99% |
| 2007 | 2007-12-31 | $3.38B | — | — |
Alcon quarterly shareholders’ equity
Q4.08
Q2.09
Q3.09
Q4.09
Q1.10
Q2.10
Q3.10
Q4.10
Q4.18
Q2.19
Q4.19
Q2.20
Q4.20
Q2.21
Q4.21
Q2.22
Q4.22
Q2.23
Q4.23
Q2.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Shareholders’ equity | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $21.59B | −$519.0M | −2.35% |
| Q1 2026 | 2026-03-31 | $22.13B | $129.0M | +0.59% |
| Q4 2025 | 2025-12-31 | $22.03B | $481.0M | +2.23% |
| Q3 2025 | 2025-09-30 | $22.09B | — | — |
| Q2 2025 | 2025-06-30 | $22.11B | $1.17B | +5.60% |
| Q1 2025 | 2025-03-31 | $22.00B | — | — |
| Q4 2024 | 2024-12-31 | $21.55B | $929.0M | +4.50% |
| Q2 2024 | 2024-06-30 | $20.94B | $1.00B | +5.03% |
| Q4 2023 | 2023-12-31 | $20.62B | $947.0M | +4.81% |
| Q2 2023 | 2023-06-30 | $19.94B | $398.0M | +2.04% |
| Q4 2022 | 2022-12-31 | $19.68B | $421.0M | +2.19% |
| Q2 2022 | 2022-06-30 | $19.54B | $477.0M | +2.50% |
| Q4 2021 | 2021-12-31 | $19.26B | $434.0M | +2.31% |
| Q2 2021 | 2021-06-30 | $19.06B | $291.0M | +1.55% |
| Q4 2020 | 2020-12-31 | $18.82B | −$481.0M | −2.49% |
| Q2 2020 | 2020-06-30 | $18.77B | −$679.0M | −3.49% |
| Q4 2019 | 2019-12-31 | $19.30B | −$3.34B | −14.74% |
| Q2 2019 | 2019-06-30 | $19.45B | — | — |
| Q4 2018 | 2018-12-31 | $22.64B | — | — |
| Q4 2010 | 2010-12-31 | $7.25B | $1.35B | +22.81% |
| Q3 2010 | 2010-09-30 | $6.73B | $1.33B | +24.57% |
| Q2 2010 | 2010-06-30 | $6.03B | $1.25B | +26.11% |
| Q1 2010 | 2010-03-31 | $6.47B | — | — |
| Q4 2009 | 2009-12-31 | $5.91B | $1.21B | +25.88% |
| Q3 2009 | 2009-09-30 | $5.40B | — | — |
| Q2 2009 | 2009-06-30 | $4.78B | — | — |
| Q4 2008 | 2008-12-31 | $4.69B | — | — |
Alcon shareholders’ equity trends
Over the last five fiscal years, Alcon's shareholders’ equity increased from $18.82B to $22.03B, a change of $3.21B. The latest reported quarter, Q2 2026, shows $21.59B.
About the metric
What shareholders’ equity means
Shareholders’ equity is the residual accounting value attributable to shareholders after liabilities are subtracted from assets. It can change through earnings, losses, dividends, share issuance, repurchases, and other comprehensive income.
Calculation and source
SEC-reported shareholders’ equity
TickerStat standardizes stockholders’ or shareholders’ equity reported in company SEC filings at each balance-sheet date. Negative equity is retained because it can be economically meaningful. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Alcon source filings ↗Community posts
Alcon completes $550 million Neurotech acquisition to enter MacTel treatment
Alcon ($ALC) has acquired Neurotech for $550 million, with additional payments dependent on commercial milestones. The transaction adds ENCELTO, a cell-based ocular therapy for adults with macular telangiectasia type 2. The product received ...
